Technologies related to Infectious diseases

Title
One-step random amplification method to detect extremely low input nucleic acids for virome, microbiome, and metagenomics in clinical and biological specimens
Ref: E-161-2017-0 | Updated: May 28, 2019
Monitoring Public Water Supply for a Variety of Pathogens
Ref: E-458-2013-0 | Updated: May 20, 2019
Monoclonal Antibody to Detect the Antiretroviral Drug Emtricitabine – for HIV Drug Adherence Monitoring
Ref: E-134-2018-0 | Updated: Apr 12, 2019
Real-Time RT-PCR Detection of Scrub Typhus Total Nucleic Acid Assay with High Sensitivity and Specificity
Ref: E-230-2017-1 | Updated: Apr 8, 2019
Encapsulated Streptococcus Compositions and Methods for Pneumococcal Vaccine, Probiotic, and Diagnostic Assay Development
Ref: E-009-2018-0 | Updated: Feb 26, 2019
Monoclonal Antibodies that Bind Zika Virus Envelope Protein for Zika Diagnostics and Research
Ref: E-030-2017-0 | Updated: Feb 26, 2019
Universal Influenza Virus Probes for Enrichment of Influenza Viral Sequences
Ref: E-032-2018-0 | Updated: Nov 8, 2018
Middle East Respiratory Syndrome Coronavirus Antibodies
Ref: E-239-2014-0 | Updated: Nov 5, 2018
Fusion Glycoprotein Vaccine for Human Metapneumovirus
Ref: E-260-2014-0 | Updated: Oct 29, 2018
Use of Rostafuroxin to Inhibit Viral Infection
Ref: E-202-2018-0 | Updated: Oct 25, 2018
Recombinant Respiratory Syncytial Virus Challenge Strain
Ref: E-235-2018-0 | Updated: Oct 25, 2018
Methods to Regulate Biofilm Development to Prevent Infection on Indwelling or Implantable Medical Devices
Ref: E-171-2013-0 | Updated: Oct 22, 2018
Hybridoma cell lines producing antibodies to RSV NS1
Ref: E-167-2018-0 | Updated: Oct 18, 2018
High-throughput assay for detection of rabies neutralizing antibodies
Ref: E-224-2018-0 | Updated: Oct 17, 2018
Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof
Ref: E-228-2016-0 | Updated: Oct 17, 2018
Prefusion Coronavirus Spike Proteins and Their Use
Ref: E-234-2016-0 | Updated: Oct 12, 2018
Recombinant RSV B1 expressing eGFP as a reporter gene
Ref: E-159-2018-0 | Updated: Oct 9, 2018
Attenuated Human Parainfluenza Virus Type 1 Expressing Ebola Virus Glycoprotein GP as an Intranasal Ebola Vaccine
Ref: E-142-2018-0 | Updated: Oct 9, 2018
Methods for Detecting Syphilis Using Synthetic Antigens
Ref: E-334-2013-0 | Updated: Sep 27, 2018
Diagnostic Assay with Modified Cardiolipin for Detecting Active Syphilis Infections
Ref: E-310-2013-0 | Updated: Sep 27, 2018
Cardiolipin Modification for Immunoassay Detection of Syphilis
Ref: E-574-2013-0 | Updated: Sep 11, 2018
Immunoassays and Methods to Diagnose Syphilis by Immobilizing a Lipoidal Antigen on a Solid Support
Ref: E-321-2013-0 | Updated: Sep 11, 2018
Method to remove human DNA when sequencing for parasite infection
Ref: E-113-2017-0 | Updated: Sep 10, 2018
Chimeric Reporter West Nile/Dengue Viruses and Their Use for Assay Development
Ref: E-126-2017-0 | Updated: Jan 11, 2019
Human Retrovirus Obtained from Infected Chimpanzee Exposure
Ref: E-251-2013-0 | Updated: Sep 10, 2018
Licensing Availability: Methods of Diagnosing and Treating CHAPLE, A Newly Identified Orphan Disease
Ref: E-251-2016-0 | Updated: Sep 7, 2018
Heterocyclic Compounds for the Treatment of Hepatitis C Virus
Ref: E-161-2014-0 | Updated: Aug 24, 2018
Antibodies for Rabies Post-exposure Prophylaxis or Antiviral Therapy of Clinical Rabies
Ref: E-263-2013-0 | Updated: Jul 16, 2018
Real-time PCR Detection of Streptococcus pneumoniae with High Sensitivity and Specificity
Ref: E-288-2013-0 | Updated: Aug 1, 2018
Assay for Early Diagnosis of Anthrax Using Monoclonal Antibodies Against Anthrax Toxin
Ref: E-071-2016-0 | Updated: Jun 22, 2018
New Anti-Influenza Virus Neuraminidase 9 (N9) Monoclonal Antibody – for Prevention or Treatment of H7N9 Influenza (Flu) A with Less Likelihood of Drug Resistance
Ref: E-200-2016-0 | Updated: Jun 20, 2018
Simple and Rapid Loop-Mediated Isothermal Amplification (LAMP)-based Assay for Mycoplasma pneumoniae Detection
Ref: E-269-2014-0 | Updated: Jun 22, 2018
The CDC 2009 Influenza A H1N1 (Flu) Pandemic Real-time RT-PCR Panel including Pandemic Influenza A and Pandemic H1 Assays
Ref: E-563-2013-0 | Updated: Jul 25, 2018
Immunoassay for the Simultaneous Detection of Functional Antibodies against Multiple Serotypes of Streptococcus pneumoniae and Other Bacteria Types
Ref: E-227-2013-0 | Updated: Jun 26, 2018
Method to Remove Mycoplasma Contamination from Virus Stocks
Ref: E-039-2018-0 | Updated: Jun 13, 2018
Novel Peptide of Streptococcus pneumoniae Surface Adhesion A (PsaA) Protein Associated with Adherence and Uses Thereof – for Vaccine Candidate, Therapeutic and Diagnostic Development
Ref: E-338-2013-0 | Updated: Jun 13, 2018
Antigens for Use in Loa Loa Microfilariae Quantitative Immunoassays
Ref: E-230-2014-0 | Updated: Jun 7, 2018
HIV-1 MW959 gp140 secreting CHO Cells
Ref: E-259-2015-0 | Updated: Jun 7, 2018
WR (Western Reserve) Strain of Vaccinia Virus with K151E Mutation in A34R Gene
Ref: E-263-2015-0 | Updated: Jun 7, 2018
Edema Factor Adenylate Cyclase Variants Having Potencies That Are Highly Dependent On the N-end Rule
Ref: E-737-2013-0 | Updated: Jun 7, 2018
Recombinant LL-SXP-1 and Plasmid Encoding LL-SXP-1 for the Immunodiagnosis of Loa Loa
Ref: E-003-2016-0 | Updated: Jun 7, 2018
Non-invasive Method for Ebola Virus Infection Detection in Great Apes and Other Wildlife Hosts
Ref: E-006-2015-0 | Updated: Jun 7, 2018
Pneumonia Virus of Mice Expression Vector PSynK-PVMJ3666
Ref: E-016-2015-0 | Updated: Jun 7, 2018
pLAS-1 Plasmid
Ref: E-034-2017-0 | Updated: Jun 7, 2018
RL-5 – Rabbit T Cell Line Derived From a Herpesvirus Ateles-induced Rabbit Tumor From the Inbred Rabbit Line B/J
Ref: E-104-2015-0 | Updated: Jun 7, 2018
Amino Acid Substitutions Mutants of Anthrax Protective Antigen, Lethal Factor, and Edema Factor
Ref: E-196-2014-0 | Updated: Jun 7, 2018
Novel UNEX Buffer and Disk for Safe Storage and Transport at Ambient Temperatures of Clinical Specimens for Molecular Testing of Pathogens
Ref: E-211-2015-0 | Updated: Jun 7, 2018
Novel Fourth Human Ebolavirus species, Bundibugyo ebolavirus – Compositions and Methods for Vaccine, Therapeutics and Highly Sensitive Diagnostic Assay Development
Ref: E-159-2013-0 | Updated: Jun 7, 2018
Real-time RT-PCR Assay for Rapid, Highly Sensitive and Specific Detection of Human Enterovirus D68 (EV-D68)
Ref: E-011-2015-0 | Updated: Jun 6, 2018
Mononegavirales Vectors expressing Chimeric Antigens
Ref: E-018-2018-0 | Updated: May 7, 2018
Chlamydial Vaccine Technologies
Ref: E-031-2006-0 | Updated: Mar 28, 2018
Protein Nanoparticles for Antigen Display in Vaccines
Ref: E-005-2017/0 | Updated: Mar 9, 2018
Protein Nanoparticles for Antigen Display in Vaccines
Ref: E-005-2017-0 | Updated: Mar 9, 2018
Novel Human Rotavirus Vaccine CDC-6 Strain for Impacted Subgroup, the Lewis Negative Population
Ref: E-285-2015-0 | Updated: May 4, 2018
Real-Time RT-PCR Detection of Rickettsia species -- PanR6/Total Nucleic Acid Assay with High Sensitivity and Specificity
Ref: E-230-2017/0 | Updated: Feb 27, 2018
Influenza A Virus Detection and Subtyping Directly from Animal Swabs and Environmental Samples
Ref: E-199-2016-0 | Updated: Jul 25, 2018
Influenza A Virus Detection and Subtyping Directly from Animal Swabs and Environmental Samples
Ref: E-199-2016/0 | Updated: Feb 27, 2018
Monoclonal Antibodies for Specific Detection of Dengue Virus Sub-type 4 in Human Serum
Ref: E-057-2016-0 | Updated: Feb 12, 2018
Zika Virus NS1 Protein Monoclonal Antibodies for Research, Development, and Novel Diagnostics
Ref: E-286-2016/0 | Updated: Feb 27, 2018
Zika Virus NS1 Protein Monoclonal Antibodies for Research, Development, and Novel Diagnostics
Ref: E-286-2016-0 | Updated: Dec 13, 2018
A Novel Thermal Method to Inactivate Rotavirus for Use in Vaccines
Ref: E-153-2013/0 | Updated: Feb 8, 2018
A Novel Thermal Method to Inactivate Rotavirus for Use in Vaccines
Ref: E-153-2013-0 | Updated: Apr 27, 2018
Compositions and Methods for Blocking Transmission of Plasmodium
Ref: E-294-2016-0 | Updated: May 16, 2018
DNA Probes to Rapidly Screen Candida glabrata Isolates for Echinocandin Resistance to Antifungal Treatment
Ref: E-132-2014/0 | Updated: Jan 9, 2018
West Nile/Zika Virus Chimeras for Inactivated Zika Vaccine and Diagnostic Assay Development
Ref: E-177-2016/0 | Updated: Dec 21, 2017
West Nile/Zika Virus Chimeras for Inactivated Zika Vaccine and Diagnostic Assay Development
Ref: E-177-2016-0 | Updated: Dec 21, 2017
Rapid Colorimetric Detection of Zika Virus from Serum and Urine Specimens by RT-LAMP (Reverse Transcription Loop-Mediated Isothermal Amplification).
Ref: E-041-2017/0 | Updated: Feb 8, 2018
Rapid Colorimetric Detection of Zika Virus from Serum and Urine Specimens by RT-LAMP (Reverse Transcription Loop-Mediated Isothermal Amplification).
Ref: E-041-2017-0 | Updated: Feb 8, 2018
Monoclonal Antibody Specific for DNA/RNA Hybrid Molecules
Ref: E-738-2013/0 | Updated: Dec 15, 2017
Human CCR3 cDNA
Ref: B-009-1998/0 | Updated: Dec 4, 2017
Real-Time PCR Assay for Detection of Carbapenem Antibiotic Resistance Genes of the IMP-type
Ref: E-156-2017-0 | Updated: Dec 5, 2017
Chimeric Dengue/Zika Viruses for Live-Attenuated Zika Vaccine Development
Ref: E-178-2016-0 | Updated: Sep 17, 2018
Plasmid pNL4-3, HIV Clone For Easy Mutational Changes
Ref: B-005-1999/0 | Updated: Dec 4, 2017
Hybridoma Cell Line 273 Producing Monoclonal Antibody Specific for Murine Leukemia Virus gp70
Ref: B-059-1994/0 | Updated: Dec 4, 2017
Hybridoma Cell Line 500 Producing Monoclonal Antibody Specific for Murine Leukemia Virus gp80
Ref: B-059-1994/1 | Updated: Dec 4, 2017
Hybridoma Cell Line 715 Producing Monoclonal Antibody Specific for Murine Leukemia Virus gp70
Ref: B-059-1994/2 | Updated: Dec 4, 2017
Real-Time PCR Assay for Detection of Carbapenem Antibiotic Resistance Genes of the IMP-type
Ref: E-156-2017/0 | Updated: Dec 5, 2017
Real-Time RT-PCR Assay for the Rapid Detection of Rabies and Other Lyssaviruses
Ref: E-070-2016-0 | Updated: Nov 20, 2017
Neutralizing Antibodies to Influenza HA and Their Use and Identification
Ref: E-061-2016-0 | Updated: Jun 22, 2018
Broadly Neutralizing Antibodies Against HIV-1 Directed to the CD4 Binding Site of HIV Envelope Protein
Ref: E-300-2009-0 | Updated: Jun 22, 2018
Chimeric Antibodies Against Hepatitis B e-Antigen
Ref: E-192-2017/0 | Updated: Jan 31, 2018
Chimeric Antibodies Against Hepatitis B e-Antigen
Ref: E-192-2017-0 | Updated: Jan 31, 2018
Development of a Transferrable Norwalk Virus Epitope and Detector Monoclonal Antibody
Ref: E-101-2013/0 | Updated: Sep 5, 2017
Pyrophosphate Analog HIV-1 Reverse Transcriptase Inhibitors
Ref: E-210-2017-0 | Updated: Aug 23, 2017
Compounds That Treat Malaria and Prevent Malaria Transmission
Ref: E-283-2009/0 | Updated: Jul 18, 2017
Methods for Treating Cerebral Edema and Restoring Blood-Brain Barrier Integrity
Ref: E-202-2015/0 | Updated: Jun 14, 2017
A Second CD4-binding Region of HIV-1 gp120 Critical for Viral Infectivity: New Methods for Treatment and Vaccine Development
Ref: E-230-2015/0 | Updated: May 3, 2017
Potent and Selective Cyclic Peptide Inhibitors of Phosphoglycerate Mutase as Anti-Infective Agents
Ref: E-229-2016-0 | Updated: Apr 26, 2017
New Cholera Vaccine and Method for Conjugating Bacterial Polysaccharides to Proteins
Ref: E-234-2011-0 | Updated: Jul 12, 2017
MDCK Cells with Enhanced Characteristics for Vaccine and Virus Production
Ref: E-173-2008-0 | Updated: May 4, 2018
A Full-Length Infectious cDNA Clone of Zika Virus from the 2015 Epidemic in Brazil as a Genetic Platform for Studies of Virus-Host Interactions and Vaccine Development
Ref: E-114-2017/0 | Updated: Apr 10, 2017
Simple and Rapid Assay to Detect Acute Subtype B and Group M HIV-1 Infections
Ref: E-014-2015/0 | Updated: Mar 15, 2017
AMA1-RON2 Complex-Based Vaccine Against Malaria
Ref: E-066-2013/0 | Updated: Mar 9, 2017
Synergistic Internal Ribosomal Entry Site (IRES)—MicroRNA-Based Approach for Attenuation of Flaviviruses and Live Vaccine Development
Ref: E-006-2017/0 | Updated: Mar 1, 2017
Single-Chain Antibodies Directed to Norovirus GI.1 and GII.4 and Their Use
Ref: E-136-2013-0 | Updated: Mar 1, 2017
Zika Virus Vaccines
Ref: E-181-2016/0 | Updated: Feb 28, 2017
Zika Virus Vaccines
Ref: E-181-2016-0 | Updated: Jun 22, 2018
Monoclonal Antibodies that Neutralize Norovirus
Ref: E-226-2011-0 | Updated: May 16, 2018
Polyvalent Influenza Virus-Like Particles (VLPs) and Use as Vaccines
Ref: E-195-2014/0 | Updated: Dec 1, 2016
Use of Roseomonas Species to Treat Eczematous (Atopic Dermatitis) Skin Disease
Ref: E-099-2016-0 | Updated: Oct 27, 2016

Pages

Subscribe to Technologies related to Infectious diseases